Given the scale-up of seasonal malaria chemoprevention (SMC) in Nigeria from 40,000 children in 2013 to over 22 million in 2022, and its expansion from the Sahel region to new geographies, this community-based platform could support the delivery of additional life-saving interventions, including vitamin A supplementation (VAS). Malaria Consortium carried out research in 2019 on the feasibility and acceptability of co-implementing VAS with SMC in Sokoto state, Nigeria. In 2021, we conducted a follow-up study in Bauchi state on the safety, equity, feasibility and cost of integration in rural and urban settings, targeting 165,000 children under five.
This poster was presented at the 71st annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: NigeriaKeywords: Monitoring and evaluation | Research | Malaria | Maternal, neonatal and child health | Seasonal malaria chemoprevention | SDG3
« Back to Publications